| Literature DB >> 27003219 |
John J Sidtis1,2, Amy G Alken1, Michele Tagliati3, Ron Alterman4, Diana Van Lancker Sidtis1,5.
Abstract
BACKGROUND: Stimulation of the subthalamic nuclei (STN) is an effective treatment for Parkinson's disease, but complaints of speech difficulties after surgery have been difficult to quantify. Speech measures do not convincingly account for such reports.Entities:
Keywords: Deep brain stimulation; Parkinson’s disease; speech; subthalamic nucleus; vowels
Mesh:
Year: 2016 PMID: 27003219 PMCID: PMC4927904 DOI: 10.3233/JPD-150739
Source DB: PubMed Journal: J Parkinsons Dis ISSN: 1877-7171 Impact factor: 5.568
Characteristics of subjects with Parkinson’s disease (PD) and bilateral deep brain stimulation of the subthalamic nuclei
| SID | AGE | PD YRS | DBS MOS | UPDRS SPEECH | LEVO | L.AMP | R.AMP |
| 103 | 54 | 14 | 44 | 1 | 250 | 3.2 | 2.8 |
| 104 | 57 | 17 | 27 | 2 | 400 | 3.0 | 3.0 |
| 106 | 59 | 17 | 9 | 3 | 600 | 3.0 | 3.0 |
| 107 | 62 | 17 | 2 | 2 | 600 | 2.5 | 2.6 |
| 108 | 61 | 11 | 12 | 1 | 600 | 2.8 | 2.8 |
| 109 | 49 | 9 | 6 | 1 | 300 | 2.6 | 2.5 |
| 110 | 62 | 11 | 56 | 2 | 600 | 3.0 | 3.3 |
| 111 | 56 | 11 | 37 | 1 | 400 | 3.0 | 3.0 |
KEY: SID = subject identifier; AGE = in years; PD YRS = duration of PD; DBS MOS = duration of DBS therapy in months; UPDRS SPEECH = the speech rating in the UPDRS motor evaluation; LEVO = daily levodopa dose in mg; L.AMP = amplitude of stimulation on the left side; R.AMP = amplitude of stimulation on the right side. All stimulation was at 185 Hz with a pulse width of 60 micro seconds. The UPDRS SPEECH ratings are 0 (normal), 1 (slight loss of expression, diction, and/or voice, 2 (monotone, slurred, but understandable), 3 (marked impairment but difficult to understand), and 4 (unintelligible).
F1 and F2 frequency values for /a/, /i/, and /u/ at measured during the initial 250 msec and at the middle point of production, for Individuals with Parkinson’s disease with their deep-brain stimulators turned on at their normal therapeutic levels and turned off, and for normal control subjects
| Condition | /a/ | /i/ | /u/ | |||
| Initial | Middle | Initial | Middle | Initial | Middle | |
| 670.7 (81) | 635.6 (77) | 310.8 (20) | 342.4 (45) | 338.0 (39) | 360.9 (56) | |
| 656.6 (84) | 653.2 (95) | 312.4 (34) | 329.0 (30) | 332.5 (39) | 332.5 (37) | |
| 708.7 (76) | 649.7 (96) | 364.8 (123) | 306.2 (24) | 335.4 (28) | 329.4 (42) | |
| 1157.2 (51) | 1090.5 (150) | 2364.7 (215) | 2159.1 (218) | 860.5 (113) | 851.4 (153) | |
| 1103.6 (58) | 1145.2 (90) | 2112.9 (258) | 2238.0 (209) | 896.2 (140) | 813.4 (133) | |
| 1183.2 (85) | 1252.0 (148) | 2403.0 (120) | 2239.0 (183) | 957.1 (139) | 981.5 (165) | |
Fig.1Vowel space for /a/, /i/, and /u/ representing the initial 250 msec of the production and a 2 sec portion at the production midpoint. The PD subjects were studied twice, once with STN-DBS on and once with the stimulation off. Parkinson’s medications were withheld for 12 hrs prior to testing in both conditions. The age-matched normal subjects were studied once.
Fig.2Average F2 values across vowels for the three study conditions. Asterisks indicate significant differences between groups (p < 0.05).